中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共12条,第1-10条 帮助

条数/页: 排序方式:
Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo 期刊论文  OAI收割
JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 1, 页码: 152-162
作者:  
Lai, Mengzhen;  Zhang, Tao;  Chen, Hao;  Song, Peiran;  Tong, Linjiang
  |  收藏  |  浏览/下载:111/0  |  提交时间:2023/04/10
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic EGFR mutation from a phase I 期刊论文  OAI收割
BMC MEDICINE, 2023, 卷号: 21, 期号: 1
作者:  
Yuankai Shi;  Jianying Zhou;  Yanqiu Zhao;  Bo Zhu;  Liangming Zhang
  |  收藏  |  浏览/下载:0/0  |  提交时间:2024/05/07
The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文  OAI收割
CANCER MEDICINE, 2022
作者:  
Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan
  |  收藏  |  浏览/下载:119/0  |  提交时间:2022/12/23
A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs 期刊论文  OAI收割
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:  
Lu, S.;  Zhang, Y.;  Zhang, G.;  Zhou, J.;  Cang, S.
  |  收藏  |  浏览/下载:104/0  |  提交时间:2022/12/23
HER2 exon 20 insertion mutations in lung adenocarcinoma with leptomeningeal metastasis: a case report and response to poziotinib 期刊论文  OAI收割
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
作者:  
Fan, Ying;  Qin, Jing;  Han, Na;  Lu, Hongyang
  |  收藏  |  浏览/下载:15/0  |  提交时间:2022/12/23
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo 期刊论文  OAI收割
CANCER SCIENCE, 2021, 页码: 12
作者:  
Liu, Yingqiang;  Lai, Mengzhen;  Li, Shan;  Wang, Yanan;  Feng, Fang
  |  收藏  |  浏览/下载:87/0  |  提交时间:2022/01/18
Effect of autoinduction and food on the pharmacokinetics of furmonertinib and its active metabolite characterized by a population pharmacokinetic model 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 10
作者:  
Zou, Hui-xi;  Zhang, Yu-feng;  Zhong, Da-fang;  Jiang, Yong;  Liu, Fei
  |  收藏  |  浏览/下载:76/0  |  提交时间:2022/01/04
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells 期刊论文  OAI收割
THORACIC CANCER, 2021, 页码: 9
作者:  
Zhang, Mi;  Quan, Haitian;  Fu, Li;  Li, Yun;  Fu, Haoyu
  |  收藏  |  浏览/下载:60/0  |  提交时间:2021/05/24
Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity 期刊论文  OAI收割
JOURNAL OF CONTROLLED RELEASE, 2021, 卷号: 329, 页码: 1249-1261
作者:  
Zhao, Pengfei;  Zhang, Jiaxin;  Wu, Aihua;  Zhang, Meng;  Zhao, Yuge
  |  收藏  |  浏览/下载:42/0  |  提交时间:2021/05/24
Discovery of a novel third generation EGFR TKI and identification of its potential mechanism of resistance 期刊论文  OAI收割
CANCER RESEARCH, 2019, 卷号: 79, 期号: 13, 页码: 2
作者:  
Zhang, Tao;  Qu, Rong;  Chen, Chengbin;  Tong, Linjiang;  Feng, Fang
  |  收藏  |  浏览/下载:14/0  |  提交时间:2020/07/01